2020年美国心脏病学会 (AHA) /美国心脏病学会 (ACC) 临床实践指导方针诊断和治疗患者的指导方针:执行摘要:美国心脏病学会/美国心脏病学会临床实践指导方针联合委员会的报告
Steve R Ommen1, Seema Mital1, Michael A Burke1
1ACC/AHA Representative.
Circulation
|November 20, 2020
概括
本指南为所有年龄段的患者诊断和管理多变性心肌病 (HCM) 提供了最新的建议. 它强调综合方法,包括基因查,风险分层和指导医学治疗.
科学领域:
- 心脏病学
- 遗传学
- 临床实践指南
背景情况:
- 缩性心肌病 (HCM) 是一种复杂的遗传性心脏病,需要更新治疗策略.
- 根据新的证据和对HCM的更好理解,现有指南需要改进.
研究的目的:
- 提供高性心肌病临床实践指南的总结.
- 为临床医生提供可行的建议和算法,用于诊断和管理成人和儿科患者的HCM.
主要方法:
- 从2010年1月到2020年4月进行了全面的文献搜索.
- 从多个数据库收集证据,包括PubMed,EMBASE和Cochrane协作.
主要成果:
- 该指南包含基于新证据的更新建议.
- 它概述了诊断工作,遗传和家庭查,风险分层和治疗方式.
- 详细介绍了指导医学治疗 (GDMT) 的组成部分,包括生活方式的改变和干预措施.
结论:
- 这份总结为实际临床应用提供了完整的指导方针.
- 建议临床医生遵守产品插入材料的药物特征.
- 该指南旨在改善心肌缩症的诊断和治疗.
相关概念视频
Heart Failure IV: Classification and Diagnostic Evaluation
1.2K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.2K
Cardiomyopathy I: Introduction and Classification
828
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy III: Hypertrophic Cardiomyopathy
810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
Cardiomyopathy VI: Nursing Management
485
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
485


